We tested the hypothesis that the variations in frontal cortex levels of IGF2 and Igf2 mRNA transcripts, and H19 promoter hypomethylation in AD are associated with altered CTCF association with the H19 ICR (Fig. S2a). The gene discussed is IGF2; the disease is Alzheimer disease.